Table 6.
Signaling Network | Cell Line | Effect on STAT3 | Results | Refs |
---|---|---|---|---|
CXCR4/JAK2/STAT3/VEGF | Human SGC-7901 and MKN45 cells | Induction | Induction of VEGF by CXCR4 Subsequent activation of JAK2/STAT3 Enhancing the migration and proliferation of cancer cells |
[285] |
NOX4/JAK2/STAT3/EMT | Six human GC cell lines (MKN-45, SGC-7901, MGC-803, BGC-823, MKN-28 and AGS) | Induction | Induction of JAK2/STAT3 by NOX4 Stimulation of EMT Promoting invasion |
[286] |
DC-SIGNR | Human GC cell lines, SGC-7901, MGC-803, BGC-823 and AGS, and the control gastric epithelial cell line GES-1 | Induction | Ensuring the growth and viability of cancer cells by the induction of the JAK2/STAT3 pathway | [287] |
HOXA11 | GC cell lines (KATO III, NCI-N87, SNU-16, AGS and SNU-16) and HEK 293T | Induction | Promoting the stemness and migration of cancer cells by the stimulation of STAT3 | [288] |
TFF1/STAT3 | AGS cells | Induction | Enhancing the proliferation and migration of cancer cells | [67] |
DARPP-32/IGF-1R/STAT3 | AGS cells | Induction | Promoting proliferation and invasion | [289] |
BMX-ARHGAP/STAT3 | Four human GC cell lines (SNU-5, MNK-45, AGS and SGC7901) and the normal gastric epithelial cell line (GES-1) | Induction | Maintaining the carcinogenesis ability of GC stem cells | [279] |
CXCL16/STAT3/Ror1 | MKN45, MKN45-Luc and KATOIII cells | Induction | Increasing progression and malignancy | [290] |
Complement C3/JAK2/STAT3 | Human SGC-7901 and MGC-803 cells, normal gastric epithelial cells (GES-1) | Induction | Poor prognosis and enhanced proliferation of cancer cells | [291] |
BTF3/JAK2/STAT3/EMT | Human gastric epithelial cell line GES-1 and human GC cell lines, including AGS, HGC-27, MKN-28, MGC-803 and SGC-7901 cells | Induction | Induction of JAK2/STAT3 by BTF3 Stimulation of EMT Enhancing the proliferation and migration of cancer cells |
[292] |
IGF1/IGF1R/STAT3/IFITM2 | GC cell lines | Induction | Enhancing the growth and metastasis of cancer cells | [293] |
IL-6/JAK2/STAT3 | GC cell lines SNU-1, MKN45, SGC7901 and MKN28 | Induction | Secretion of IL-6 by CAMs Stimulation of JAK2/STAT3 by IL-6 |
[294] |
TNF-α/IL-6/STAT3 | SGC7901 cells | Induction | Induction of EMT Ensuring the metastasis of cancer cells |
[295] |
Succinate/STAT3/VEGF | Human gastric mucosal epithelial cell line GES-1 and human GC cell lines AGS (low-differentiated human gastric adenocarcinoma), NCI-N87 (well-differentiated human carcinoma), BGC-823 (low-differentiated human gastric adenocarcinoma) and SGC-7901 (moderate-differentiated human gastric adenocarcinoma) | Induction | Induction of VEGF by succinate via STAT3 overexpression Increasing viability and invasion of cancer cells |
[296] |
Cyclophilin B/STAT3/miR-520d-5p | GC cell lines | Induction | There is feedback consisting of the downregulation of miR-520d-5p and upregulation of cyclophilin B and STAT3, leading to the enhanced growth of cancer cells | [297] |
CMTM3/STAT3/Twist1/EMT | Human GC cell line SGC-7901 | Inhibition | Downregulation of STAT3 by CMTM3 Suppressing metastasis |
[298] |
HCCR/STAT3 | Human GC cell lines AGS, MKN-45, BGC823, MGC803, HGC27, SGC7901, NCI-N87 | Induction | Triggering chemoresistance | [299] |
GRIM19/STAT3 | Immortalized normal gastric epithelial cell line GES-1, human embryonic kidney HEK-293 cells, human GC SGC-7901 and BGC-823 cell lines | Inhibition | Suppressing STAT3 Induction of apoptosis |
[300] |
ROS/IL-6/STAT3 | AGS cells | Induction | Enhanced generation of ROS by H. pylori Stimulation of IL-6/STAT3 Enhanced proliferation and invasion of cancer cells |
[301] |
IL-6/STAT3/VEGF | GC cell lines including SGC-7901, MGC, MKN-28 and AGS | Induction | Promoting invasion and angiogenesis Induction of STAT3 and subsequent activation of VEGF |
[302] |
IL-17/STAT3/VEGF | Human GC (AGS) cells and other cells SGC7901, MKN 45 and BGC823 | Induction | Enhancing growth Induction of angiogenesis Activation of STAT3/VEGF |
[303] |